Læknablaðið - 15.05.1998, Blaðsíða 17

LÆKNABLAÐIÐ 1998; 84
379
HEIMILDIR
1. Thomas ED. The Nobel Lectures in Immunology. The No-
bel Prize for Physiology or Medicine, 1990. Bone marrow
transplantation—past, present and future. Scand J
Immunol 1994; 39: 339-45.
2. Wuest DL. Transfusion and stem cell support in cancer
treatment. Hematol Oncol Clin North Am 1996; 10:
397-429.
3. Goodman JW, Hodgson GS. Evidence for stem cells in the
peripheral blood of mice. Blood 1962; 10: 702-14.
4. Fraser CC, Eaves CJ, Szilvassy SJ, Humphries RK. Ex-
pansion in vitro of retrovirally marked totipotent
hematopoietic stem cells. Blood 1990; 76: 1071-6.
5. Orlic D, Bodine DM. What defines a pluripotent
hematopoietic stem cell (PHSC): will the real PHSC
please stand up (editorial). Blood 1994; 84: 3991-4.
6. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF,
Shaper JH. Antigenic analysis of hematopoiesis. III. A
hematopoietic progenitor cell surface antigen defined by a
monoclonal antibody raised against KG-la cells. J
Immunol 1984; 133: 157-65. .
7. Knapp W, Strobl H, Scheinecker C, Bello-Fernandez C,
Majdic O. Molecular characterization of CD34+ human
hematopoietic progenitor cells. Ann Hematol 1995; 70:
281-96.
8. Bender JG, Unverzagt KL, Walker DE, Lee W, Van ED,
Smith DH, et al. Identification and comparison of CD34-
positive cells and their subpopulations from normal peri-
pheral blood and bone marrow using multicolor flow
cytometry. Blood 1991; 77: 2591-6.
9. Egeland T, Gaudernack G. CD34. The gateway to the
study of lymphohematopoietic progenitor and leukemic
cells. Immunologist 1994; 2: 65-70.
10. Scott MA, Gordon MY. In search of the haemopoietic
stem cell. Br J Haematol 1995; 90: 738-43.
11. Metcalf D. The molecular control of cell division, differ-
entiation commitment and maturation in hemopoietic
cells. Nature 1989; 339: 27-30.
12. Prosper F, Stroncek D, Verfaille CM. Phenotypic and
functional characterization of long-term culture-initiating
cells present in peripheral blood progenitor collections of
normal donors treated with granulocyte colony-stimulat-
ing factor. Blood 1996; 88: 2033-42.
13. Gratwohl A, Hermans J, Baldomero H. Hematopoietic
precursor cell transplants in Europe: activity in 1994.
Report from the European Group for Blood and Marrow
Transplantation (EBMT). Bone Marrow Transplant 1996;
17: 137-48.
14. Demirer T, Buckner CD, Bensinger WI. Optimization of
peripheral blood stem cell mobilization. Stem Cells 1996;
14: 106-16.
15. Almici C, Carlo SC, Wagner JE, Rizzoli V. Umbilical cord
blood as a source of hematopoietic stem cells: from re-
search to clinical application. Haematologica 1995; 80:
473-9.
16. Han P, Hodge G, Story C, Xu X. Phenotypic analysis of
functional T-lymphocyte subtypes and natural killer cells
in human cord blood: relevance to umbilical cord blood
transplantation. Br J Haematol 1995; 89: 733-40.
17. Broxmeyer HE. Questions to be answered regarding um-
bilical cord blood hematopoietic stem and progenitor cells
and their use in-transplantation (see comments). Trans-
fusion 1995; 35: 694-702.
18. Kvalheim G, Pharo A, Holte H, Jakobsen E, Kval0y S,
Beiske K, et al. H0ydosebehandling av kreft ved bruk av
CD34-positive celler som stamcellestptte. Tidsskr Nor
Lægeforen 1996; 116: 2542-6.
19. Boyum A. Isolation of lymphocytes, granulocytes and
macrophages. Scand J Immunol 1976; 5: 9-15.
20. Couthino LH, Gilleece MH, De Wynter EA, Will A, Testa
G. Clonal and long term cultures using human bone mar-
row. Haemopoiesis. A practical approach. New York: IRL
Press 1993: 79-106.
21. Steen R, Tjonnfjord GE, Egeland T. Comparison of the
phenotype and clonogenicity of normal CD34+ cells from
umbilical cord blood, granulocyte colony-stimulating
factor-mobilized peripheral blood, and adult human bone
marrow. J Hematotherapy 1994; 3: 253-62.
22. Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol
AJ, Bradley BA, Hows JM. Optimal cryopreservation of
human umbilical cord blood. Bone Marrow Transplant
1996; 18: 725-31.
23. Bertolini F, Lazzari L, Lauri E, Corsini C, Castelli C, Gor-
ini F, et al. Comparative study of different procedures for
the collection and banking of umbilical cord blood. J
Hematotherapy 1995; 4: 29-36.
24. Johnsen HE, Knudsen LM. Nordic flow cytometry stand-
ards for CD34+ cell enumeration in blood and leukapher-
esis products: report from the second nordic workshop. J
Hematotherapy 1996; 5: 237-45.
25. Rowley SD. Hematopoietic stem cell cryopreservation: a
review of current techniques. J Hematotherapy 1992; 1:
233-50.
26. Wissel ML, Lasky LC. Progenitor processing and cryo-
preservation. In: Brecher ME, Lasky LC, Sacher RA, Issitt
LA, eds. Hemtaopoietic progenitor cells: processing,
standards and practice. Maryland: AABB 1995: 109-24.
27. Rowley SD, Bensinger WI, Gooley TA, Buckner CD.
Effect of cell concentration on bone marrow and peripher-
al blood stem cell cryopreservation. Blood 1994; 83:
2731-6.
28. Williams CD, Goldstone AH, Pearce RM, Philip T, Hart-
mann O, Colombat P, et al. Purging of bone marrow in
autologous bone marrow transplantation for non-Hodg-
kin's lymphoma: a case-matched comparison with un-
purged cases by the European blood and marrow trans-
plant lymphoma registry. J Clin Oncol 1996; 14: 2454-64.
29. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-
Yee I. The ISHAGE guidelines for CD34+ cell deter-
mination by flow cytometry. J Hematotherapy 1996; 5:
213-26.
30. Wunder E, Sovalat H, Fritsch G, Silvestri F, Hénon P,
Serke S. Report on the European workshop on peripheral
blood stem cell determination and standardization-Mul-
house, France. J Hematotherapy 1992; 1: 131-42.
31. Fritsch G, Printz D, Stimpfl M, Dworzak MN, Witt V,
Pötschger U, et al. Quantification of CD34+ cells:
comparison of methods. Transfusion 1997; 37: 775-84.
32. Lumley MA, Burgess R, Billingham LJ, McDonald DF,
Milligan DW. Colony counting is a major source of vari-
ation in CFU-GM results between centres. Br J Haematol
1997; 97: 481-4.